Efficacy and safety of Sanfeng Tongqiao Diwan in the treatment of upper airway cough syndrome: a randomized, double-blind, placebo-controlled clinical study.

Background: Sanfeng Tongqiao Diwan has shown the potential to alleviate acute, recurrent, and chronic rhinitis in adults based on available studies. However, the evidence for its application in upper airway cough syndrome (UACS) is unclear. The purpose of this study was thus to investigate the efficacy and safety of Sanfeng Tongqiao Diwan in the treatment of UACS. Methods: This was a single-center, randomized, double-blind, placebo-controlled clinical trial. A total of 60 patients who satisfied the inclusion criteria were randomly divided into experimental and placebo groups in a 1:1 ratio. The experimental group was given Sanfeng Tongqiao Diwan, and the placebo group was given a simulant for 14 consecutive days. The follow-up period was 15 days. The primary outcome was the total effective rate. The secondary outcomes included clinical efficacy, Visual Analogue Scale (VAS) of related symptoms, and Leicester Cough Questionnaire in Mandarin-Chinese (LCQ-MC) scores before and after the treatment. Additionally, the safety was also evaluated. Results: The total effective rate in the experimental group was 86.6% (26/30), which was significantly higher than the 7.1% (2/28) in the placebo group (difference 79.6; 95% CI: 57.0 to 89.1; P<0.001). Nasal congestion, runny nose, cough, postnasal drip, and overall symptoms in the experimental group were significantly lower than those in the placebo group after treatment (3.7±1.5 vs. 5.0±1.1, 3.6±1.3 vs. 5.9±1.1, 3.8±1.2 vs. 6.8±1.3, 3.5±1.4 vs. 6.1±1.5, 3.8±2.0 vs. 7.3±1.4, respectively; all P values <0.001). After treatment, the LCQ-MC score in the experimental group was significantly higher than that in the placebo group (all P values <0.001). The blood eosinophil count in the placebo group was significantly higher after treatment than before treatment (P=0.037). No abnormalities were found in liver or renal indicators during the treatment period in the 2 groups, and no adverse reactions occurred. Conclusions: Sanfeng Tongqiao Diwan improved the symptoms and living quality of patients with UACS and showed acceptable safety. The results of this trial represent rigorous clinical evidence for the application of Sanfeng Tongqiao Diwan and further support a new option in UACS treatment. Trial Registration: Chinese Clinical Trial Registry ChiCTR2300069302.

Distribution characteristics, air-water exchange, ozone formation potential and health risk assessments of VOCs emitted from typical coking wastewater treatment process.

Coking industry has been considered as important source of volatile organic compounds (VOCs) emissions. However, few studies have emphasized the occurrence and adverse effects of VOCs from coking wastewater treatment processes. In this research, pollution profiles of both air and water phase VOCs in a typical coking wastewater treatment plant were investigated in terms of distribution characteristics, air-water exchange, ozone formation potential (OFP) and associated human health risks. Thirty VOCs were detected in the air phase, in which benzene and naphthalene were found to be the major VOCs with total contribution of 87.81 %. Nineteen VOCs were detected in the water phase, in which benzene, naphthalene and toluene contribute most to total VOCs with total contribution of 75.1 %. The regulating tank (RT) was the major source of VOCs, and the emission rate of total VOCs from all unites was 2711.03 g/d with annual emission of 0.99 t. The emission factor was estimated to be 1.36 g VOCs/m3 wastewater. The air-water exchange was assessed using the Fugacity model, and water-to-air volatilization was predominant based on the net flux of air-water exchange. OFP evaluated by emission factor indicated that the total OFP in RT was the highest (1.52 g O3/m3 wastewater), and toluene contributed 41.8 % of the total OFP, followed by naphthalene accounting for 38.7 % The total carcinogenic risks were in the range of 8.60 × 10-6 to 2.18 × 10-3, in which the RT exceeded the significant risk threshold (>1 × 10-4). The non-carcinogenic risks of hazard quotient value in RT also exceeded the risk threshold (>1), and naphthalene was the major contributor accounting for 79.02 %. These results not only provided comprehensive knowledge on pollution profiles and environmental risks of VOCs during coking wastewater treatment processes, but also facilitated the implement of VOCs regulation and occupational health protection strategies in coking industries.

Comparative Study of Biochar Modified with Different Functional Groups for Efficient Removal of Pb(II) and Ni(II).

The potential application of biochar in water treatment is attracting interest due to its sustainability and low production cost. In the present study, H3PO4-modified porous biochar (H-PBC), ethylenediaminetetraacetic acid-modified porous biochar (E-PBC), and NaOH-modified porous biochar (O-PBC) were prepared for Ni(II) and Pb(II) adsorption in an aqueous solution. Scanning electron microscopy (SEM), X-ray diffraction analysis (XRD), Brunauer-Emmett-Teller analysis (BET), and Fourier-transform infrared (FT-IR) spectroscopy were employed to characterize the as-obtained samples, and their capacities for Ni(II) and Pb(II) adsorption were determined. SEM showed that H-PBC retained the hierarchical porous structure of pristine biochar. FT-IR showed that H-PBC possessed abundant oxygen-containing and phosphorus-containing functional groups on the surface. BET analysis demonstrated that the surface areas of H-PBC (344.17 m2/g) was higher than O-PBC (3.66 m2/g), and E-PBC (1.64 m2/g), respectively. H-PBC, E-PBC, and O-PBC all exhibited excellent performance at Ni(II) and Pb(II) adsorption with maximum adsorption capacity of 64.94 mg/g, 47.17 mg/g, and 60.24 mg/g, and 243.90 mg/g, 156.25 mg/g, and 192.31 mg/g, respectively, which were significantly higher than the adsorption capacity (19.80 mg/g and 38.31 mg/g) of porous biochar (PBC). Pseudo-second order models suggested that the adsorption process was controlled by chemical adsorption. After three regeneration cycles, the Ni(II) and Pb(II) removal efficiency with H-PBC were still 49.8% and 56.3%. The results obtained in this study suggest that H-PBC is a promising adsorbent for the removal of heavy metals from aqueous solutions.

Compact microring resonators integrated with grating couplers working at 2 µm wavelength on silicon-on-insulator platform.

Compact all-pass and add-drop microring resonators (radius=10 µm) integrated with grating couplers working at 2 µm wavelength are designed, fabricated, and characterized on a commercial 340-nm-thick-top-silicon silicon-on-insulator platform. They are suitable for high-volume integrated optical circuits at 2 µm wavelength as the fabrication process involved are uncomplicated and complementary metal-oxide-semiconductor (CMOS)-process compatible, thus making them more convenient to be utilized. The performance of the grating couplers, based on four most important parameters, has been simulated and optimized. The simulation and experimental results of grating couplers show the lowest coupling loss of 4.5 dB and 6.5 Db, respectively. By utilizing the grating couplers to couple light in and out from the chip, the designed microring resonators have been tested. The experimental results of microring resonators show that an extinction ratio of 12 dB and a quality factor of 11,200 can be achieved. To the best of our knowledge, this is thus far the smallest microring resonator ever demonstrated at this wavelength.

Molecular cloning and characterization of α-amylase/subtilisin inhibitor from rhizome of Ligusticum chuanxiong.

OBJECTIVES: To clone and characterize a novel bi-functional α-amylase/subtilisin inhibitor (LASI) from the rhizome of Ligusticum chuanxiong, a traditional Chinese medicine. RESULTS: The LASI showed strong homology with members of the Kunitz trypsin inhibitor family. Its putative amino acid sequence has a 40 % identity with that of the α-amylase/subtilisin inhibitor from rice. LASI gene without signal peptide was expressed in E. coli Rosetta. After purification, the recombinant LASI protein was inhibitory against not only α-amylase from porcine pancreas, Helicoverpa armigera, Spodoptera litura and Plutella xylostella, but also subtilisin A, but not against trypsin or chymotrypsin. In addition, the expression level of LASI in rhizome was higher than that in leaf and LASI expression was enhanced by salt, chilling and drought treatment. CONCLUSIONS: This is the first member of the Kunitz-protease inhibitor family identified in traditional Chinese medicine and it might be involved in the plant defense responses against lepidopterous pests, microorganisms and abiotic stresses.

Molecular cloning and characterization of caffeic acid 3-O-methyltransferase from the rhizome of Ligusticum chuanxiong.

OBJECTIVES: To clone and characterize caffeic acid 3-O-methyltransferase (LcCOMT) from the rhizome of Ligusticum chuanxiong, a traditional medicinal herb having a high content of ferulic acid. RESULTS: LcCOMT encoded an ORF of 362 amino acids with a calculated MW of 39,935 Da and pI of 5.94. Polygenetic tree indicated that LcCOMT was attributed to a new member of COMTs in plants. The recombinant LcCOMT was expressed in E. coli. HPLC and (1)H NMR analyses of purified LcCOMT protein confirmed that it could catalyze caffeic acid to produce ferulic acid in vitro. The further site-mutagenesis proved that His268 was one key catalytic residue. In addition, the substantial changing expression level of LcCOMT under chilling treatment suggested that LcCOMT might play important role in the accumulation of ferulic acid under chilling treatment. CONCLUSIONS: This is the first report of the isolation and characterization of a COMT clone from traditional medicine containing high contents of pharmaceutical ferulic acid.

Highly integrated 3×3 silicon thermo-optical switch using a single combined phase shifter for optical interconnects.

We report on an experimental 3×3 thermo-optical switch on silicon on insulator. By controlling a single combined phase shifter, light from any input waveguide can be directed to any output waveguide, showing a simple control method and highly integrated structure as compared to the conventional multiway optical switches. Furthermore, the proposed optical switch can be generalized to be a 1×N and N×N optical switch without an extra phase shifter. The switch is fabricated by complementary metal oxide semiconductor technology. By experiment, full 3×3 switching functionality is demonstrated at a wavelength of 1.55 µm, with an average cross talk of -11.1 dB and a power consumption of 97.5 mW.